[go: up one dir, main page]

BRPI0814027A2 - Processo de produção de formas farmacêuticas secas hidrodispersíveis - Google Patents

Processo de produção de formas farmacêuticas secas hidrodispersíveis

Info

Publication number
BRPI0814027A2
BRPI0814027A2 BRPI0814027-8A2A BRPI0814027A BRPI0814027A2 BR PI0814027 A2 BRPI0814027 A2 BR PI0814027A2 BR PI0814027 A BRPI0814027 A BR PI0814027A BR PI0814027 A2 BRPI0814027 A2 BR PI0814027A2
Authority
BR
Brazil
Prior art keywords
hydrodispersible
production process
pharmaceutical forms
dry pharmaceutical
dry
Prior art date
Application number
BRPI0814027-8A2A
Other languages
English (en)
Inventor
Patrice Binay
Original Assignee
Coretecholding
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coretecholding filed Critical Coretecholding
Publication of BRPI0814027A2 publication Critical patent/BRPI0814027A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0814027-8A2A 2007-07-06 2008-07-07 Processo de produção de formas farmacêuticas secas hidrodispersíveis BRPI0814027A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0704874A FR2918277B1 (fr) 2007-07-06 2007-07-06 Nouveau procede de production de formes pharmaceutiques seches hydrodispersibles et les compositions hydrodispersibles ainsi obtenues
PCT/FR2008/000973 WO2009024686A2 (fr) 2007-07-06 2008-07-07 Procede de production de formes pharmaceutiques seches hydrodispersibles

Publications (1)

Publication Number Publication Date
BRPI0814027A2 true BRPI0814027A2 (pt) 2015-02-03

Family

ID=39469562

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0814027-8A2A BRPI0814027A2 (pt) 2007-07-06 2008-07-07 Processo de produção de formas farmacêuticas secas hidrodispersíveis

Country Status (9)

Country Link
US (1) US20130064897A1 (pt)
EP (1) EP2192894A2 (pt)
JP (1) JP5560188B2 (pt)
KR (1) KR20100038188A (pt)
BR (1) BRPI0814027A2 (pt)
CA (1) CA2694059A1 (pt)
FR (1) FR2918277B1 (pt)
RU (1) RU2497502C2 (pt)
WO (1) WO2009024686A2 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9003296L (sv) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab Foerfarande foer att formulera laekemedel
FR2722984B1 (fr) 1994-07-26 1996-10-18 Effik Lab Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AU778931B2 (en) * 1999-12-20 2004-12-23 Nicholas J. Kerkhof Process for producing nanometer particles by fluid bed spray-drying
DE10244681A1 (de) * 2002-09-24 2004-04-08 Boehringer Ingelheim International Gmbh Neue feste Telmisartan enthaltende pharmazeutische Formulierungen und deren Herstellung
US20040185170A1 (en) * 2003-03-21 2004-09-23 Shubha Chungi Method for coating drug-containing particles and formulations and dosage units formed therefrom
JP5069001B2 (ja) 2003-10-10 2012-11-07 ベロクシス ファーマシューティカルズ エー／エス フィブラートを含む固体投与形態
US20050181049A1 (en) * 2003-11-19 2005-08-18 Dong Liang C. Composition and method for enhancing bioavailability
KR100629771B1 (ko) * 2004-01-27 2006-09-28 씨제이 주식회사 결정성이 감소되거나 무정형화된 올티프라즈의 제조방법
US7635745B2 (en) * 2006-01-31 2009-12-22 Eastman Chemical Company Sulfopolyester recovery

Also Published As

Publication number Publication date
JP2010532336A (ja) 2010-10-07
KR20100038188A (ko) 2010-04-13
WO2009024686A3 (fr) 2009-04-23
RU2497502C2 (ru) 2013-11-10
WO2009024686A2 (fr) 2009-02-26
US20130064897A1 (en) 2013-03-14
FR2918277B1 (fr) 2012-10-05
EP2192894A2 (fr) 2010-06-09
CA2694059A1 (fr) 2009-02-26
RU2010103999A (ru) 2011-08-20
JP5560188B2 (ja) 2014-07-23
FR2918277A1 (fr) 2009-01-09

Similar Documents

Publication Publication Date Title
BRPI0814027A2 (pt) Processo de produção de formas farmacêuticas secas hidrodispersíveis
BRPI0818887A2 (pt) Processo de produção de açúcares
BRPI0814291A2 (pt) Processo para produção de alcoóis
BRPI0914675A2 (pt) processo de secagem por atomização
BRPI0914670A2 (pt) processo de secagem por atomização
BRPI0816478A2 (pt) Processo para produção de celulases
PT2155838E (pt) Processo de produção de hidrocarbonetos ramificados
BRPI0821944A2 (pt) Processo
BRPI1013929A2 (pt) processo de fabricação de um substrato fibroso, substrato fibroso, e, utilização de um substrato fibroso
BRPI0910820A2 (pt) processo de preparação de sílica precipitada, sílica precipitada, e, utilização de uma sílica
BRPI0910916A2 (pt) Processo para a produção de um dianidroaçúcar
BRPI0720070A2 (pt) Processo para produção de produtos de tecido
BRPI0810238A2 (pt) Processo para produção de pcc
BRPI0919868A2 (pt) processo
BRPI1013615A2 (pt) camada funcional elétrica, processo de produção e uso dela
BRPI0809681A2 (pt) processo para fabricação de polímeros
BRPI0806503A2 (pt) Processo aperfeiçoado de secagem por pulverização
BRPI0921374A2 (pt) processo
PT2155839E (pt) Processo de produção de hidrocarbonetos ramificados
BRPI0814673A2 (pt) Pneumático e processo de fabricação de um pneumático
BRPI0821801A2 (pt) Zeólito e processo de preparação de um zeólito.
BRPI0915572A2 (pt) processo para a fabricação de epicloroidrina
BR112012014943A2 (pt) processo de secagem por atomização
BRPI1009095A2 (pt) processo de secagem por atomização
PT2165971T (pt) Processo de hidrotratamento

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS ANUIDADES EM DEBITO.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2332 DE 15/09/2015.